US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARS PHARMACEUTICALS INC

18.35

+0.48002.69%

Post-market: 18.350.00000.00%19:15 EDT

Volume:2.06M

Turnover:37.73M

Market Cap:1.80B

PE:-114.12

High:18.63

Open:17.94

Low:17.78

Close:17.87

Loading ...

Overview Company News Filings

Discover LifeMD And 2 Other High Growth Stocks With Strong Insider Ownership

Simply Wall St.

Three Growth Stocks With Strong Insider Confidence

Simply Wall St.

Dell, Bitfarms, Bloom Energy, and More Stocks See Action From Activist Investors -- Barrons.com

High Insider Confidence In These Growth Stocks For July 2025

Simply Wall St.

Top Growth Companies With Insider Stakes July 2025

Simply Wall St.

ARS Pharmaceuticals announces UK MHRA approval of EURneffy

ARS Pharmaceuticals Inc. Secures UK Regulatory Approval for EURneffy, the First Needle-Free Adrenaline Treatment for Severe Allergies

Top Growth Companies With Strong Insider Ownership In July 2025

Simply Wall St.

Top Growth Stocks With High Insider Ownership July 2025

Simply Wall St.

Eric Karas, Chief Commercial Officer, Reports Disposal of Common Shares of ARS Pharmaceuticals Inc

James E. Flynn Reports Disposal of Common Shares of ARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Eric Karas, Chief Commercial Officer, Reports Disposal of Common Shares in ARS Pharmaceuticals Inc

William Blair Remains a Buy on ARS Pharmaceuticals (SPRY)

Brent L. Saunders, Director, Reports Disposal of Common Shares in ARS Pharmaceuticals Inc

Alexander A. Fitzpatrick, Chief Legal Officer, Reports Disposal of Common Shares of ARS Pharmaceuticals Inc

Raymond James Keeps Their Buy Rating on ARS Pharmaceuticals (SPRY)

Stock Track | ARS Pharmaceuticals Soars 11.57% Following Strong Q1 Results and Positive Outlook

Stock Track | ARS Pharmaceuticals (SPRY) Soars 11.57% as Q1 Results Beat Expectations

Stock Track | ARS Pharmaceuticals Soars 5.79% After-Hours on Strong Q1 Revenue Beat and In-Line EPS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SPRY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":18.35,"timestamp":1753732800000,"preClose":17.87,"halted":0,"volume":2062698,"hourTrading":{"tag":"盘后","latestPrice":18.35,"preClose":18.35,"latestTime":"19:15 EDT","volume":21252,"amount":389939.53,"timestamp":1753744531363},"delay":0,"floatShares":53634396,"shares":98213561,"eps":-0.160792,"marketStatus":"Not Yet Opened","change":0.48,"latestTime":"07-28 16:00:00 EDT","open":17.94,"high":18.63,"low":17.78,"amount":37734176.258196,"amplitude":0.047566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.160792,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753776000000},"marketStatusCode":0,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":17.87,"preHourTrading":{"tag":"盘前","latestPrice":17.99,"preClose":17.87,"latestTime":"09:29 EDT","volume":412,"amount":7411.930264,"timestamp":1753709399999},"postHourTrading":{"tag":"盘后","latestPrice":18.35,"preClose":18.35,"latestTime":"19:15 EDT","volume":21252,"amount":389939.53,"timestamp":1753744531363},"volumeRatio":1.556535,"impliedVol":0.7984,"impliedVolPercentile":0.58},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":53634396,"roa":"-6.10%","roe":"-6.91%","lyrEps":0.082507,"volumeRatio":1.556535,"shares":98213561,"dividePrice":0,"high":18.63,"amplitude":0.047566,"preClose":17.87,"low":17.78,"week52Low":8.9055,"pbRate":"7.87","psRate":"18.56","week52High":18.9,"institutionHeld":0,"latestPrice":18.35,"eps":-0.160792,"divideRate":0,"volume":2062698,"delay":0,"ttmEps":-0.160792,"open":17.94,"prevYearClose":10.55,"prevWeekClose":17.87,"prevMonthClose":17.45,"prevQuarterClose":17.45,"fiveDayClose":17.85,"twentyDayClose":18.2,"sixtyDayClose":13.97},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555046727","title":"Discover LifeMD And 2 Other High Growth Stocks With Strong Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2555046727","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555046727?lang=en_us&edition=fundamental","pubTime":"2025-07-29 01:05","pubTimestamp":1753722330,"startTime":"0","endTime":"0","summary":"As the S&P 500 and Nasdaq Composite hit new highs, investors are closely watching for trade developments and major tech earnings that could influence market trends. In this climate of heightened anticipation, stocks with strong insider ownership can be particularly appealing, as they often signal confidence from those closest to the company.","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/643468691-main-header/1669268249538","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/643468691-main-header/1669268249538"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/media/nyse-vtex/vtex/news/discover-lifemd-and-2-other-high-growth-stocks-with-strong-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4141","LU0106831901.USD","BK4585","BK4023","LFMD","VTEX","LU0231459107.USD","SPRY","BK4539","BK4139","LU0594300419.USD","SES","LU2265009873.SGD","LU0594300179.USD","LU0057025933.USD","LU0650527681.SGD","BK4588","BK4096","BK4543","BK4170","LU0053671581.USD","LU1668664300.SGD","LU0069063385.USD","LU0472753341.HKD","LU2290526834.HKD","LU1804176565.USD","BK4167","BK4555","BK4213","BK4091","BK4183","NIU","CRDO","BK4077","DFS","LU1861220207.SGD","FTCI","PROP","LU2360107168.USD","NIU.AU","ATAT","LU1861217088.USD","BK4142","BK4146","ONON","LU0289739343.SGD","LU0289961442.SGD","WBX"],"gpt_icon":1},{"id":"2555705499","title":"Three Growth Stocks With Strong Insider Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2555705499","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555705499?lang=en_us&edition=fundamental","pubTime":"2025-07-28 19:05","pubTimestamp":1753700752,"startTime":"0","endTime":"0","summary":"The United States market has shown positive momentum, climbing by 1.4% over the past week and up 17% over the last 12 months, with earnings forecast to grow by 15% annually. In this environment, growth stocks with strong insider ownership can be particularly appealing as they often signal confidence from those who know the company best.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9612016-choice2-main-header/1585186746976","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612016-choice2-main-header/1585186746976"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-mmi/marcus-millichap/news/three-growth-stocks-with-strong-insider-confidence-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7081","BK4539","LU0231459107.USD","BK4079","PROP","CRDO","BK4141","DUOL","LU0053671581.USD","LU0594300419.USD","LU0650527681.SGD","WBX","LU1861215975.USD","LU1861220033.SGD","BK4588","SMCI","BK4170","BK4096","BK4023","BK4204","BK4213","IE0034390439.USD","SPRY","MMI.AU","ATAT","LU0594300179.USD","BK4558","LU2290526834.HKD","MMI","BK4543","NIU.AU","BK4585","BK4142","LU0605514214.HKD","BK4149","IE00B19Z6F94.USD","ALAB","BK4139","BK4613","FTCI","BK4091","LU2360107168.USD","AEBI","NIU","BK4555"],"gpt_icon":1},{"id":"2554792805","title":"Dell, Bitfarms, Bloom Energy, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2554792805","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554792805?lang=en_us&edition=fundamental","pubTime":"2025-07-26 04:44","pubTimestamp":1753476240,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from July 17 through July 23, 2025. Source: VerityData. Dell Technologies  Silver Lake lowered its stake in the computer maker to 58,887,472 shares. Silver Lake and its affiliates did so through the sale of 2,707,804 Dell Technologies shares from June 9 through July 16, 2025, at per share prices ranging from $112.83 to $128.27. Following the sales, Silver Lake owns 14.7% of Dell Technologies' outstanding stock. Shares of Dell Technologies have gained approximately 9.1% in value since the beginning of this year.ARS Pharmaceuticals  Deerfield Capital lowered its stake in the pharmaceutical company to 8,633,537 shares. Deerfield Capital did so through the sale of 1,090,971 ARS Pharmaceuticals shares from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1267930227.SGD","LU0128525689.USD","LU0476273544.USD","LU2357125470.USD","LU0823414551.USD","BK4211","BITF","BK4588","BK4515","DVMT","BK4182","DELL","BK4170","LU0444973449.USD","LENZ","LU0823414478.USD","ISBC","BK4021","LU2249611893.SGD","BK4535","BK4595","LU0267386448.USD","BK4539","GNK","LU0957808578.USD","LU0310800965.SGD","BK4007","BK4600","LU1642822529.SGD","LU2294711713.HKD","BK4543","LU0052756011.USD","LU2506951792.HKD","BK4023","BK4541","LU1815336760.USD","BE","BK4585","SPRY","LU0444971666.USD"],"gpt_icon":0},{"id":"2554834736","title":"High Insider Confidence In These Growth Stocks For July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2554834736","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554834736?lang=en_us&edition=fundamental","pubTime":"2025-07-25 01:05","pubTimestamp":1753376745,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 1.7%, contributing to an impressive 18% climb over the past year, with earnings projected to grow by 15% annually in the coming years. In this favorable environment, growth companies with high insider ownership often signal strong confidence from those closest to the business, making them noteworthy considerations for investors seeking potential opportunities.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-wk/workiva/news/high-insider-confidence-in-these-growth-stocks-for-july-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CRDO","WBX","BK4139","LU1169590202.USD","ATAT","BK4213","STGW","BK4539","BK4009","BK4096","BK4006","LU1861215975.USD","LU1815336091.USD","BK4558","BK4141","LU0053671581.USD","WK","LU0757428866.USD","SPRY","LU0231459107.USD","LU1861220033.SGD","METC","LU0594300419.USD","BK4555","LU0566484027.USD","LU1169589451.USD","LU0650527681.SGD","BK4142","BK4091","NIU.AU","ENVX","LU1559883803.SGD","NIU","PROP","BK4023","FTCI","SMCI","LU2360107168.USD","BK4585","BK4170","BK4543","LU2290526834.HKD","BK4588","LU0605514214.HKD","LU0594300179.USD"],"gpt_icon":1},{"id":"2553128317","title":"Top Growth Companies With Insider Stakes July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553128317","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553128317?lang=en_us&edition=fundamental","pubTime":"2025-07-22 01:05","pubTimestamp":1753117552,"startTime":"0","endTime":"0","summary":"As the U.S. stock market reaches new heights with the S&P 500 and Nasdaq hitting record highs, investors are buoyed by strong earnings reports and positive economic data despite ongoing trade uncertainties. In this thriving environment, growth companies with high insider ownership can offer unique insights into potential investment opportunities, as insiders' stakes often signal confidence in a company's long-term prospects.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/top-growth-companies-with-insider-stakes-july-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4555","BK4023","NIU.AU","LU0053671581.USD","BK4091","LU2360107168.USD","ETON","BK4141","BK4166","BK4539","LU1861215975.USD","LU0231459107.USD","BK4558","PROP","LU0594300419.USD","DAVE","NIU","BK4543","FTCI","LU2290526834.HKD","BK4213","BK4096","BK4170","ATAT","BK4588","BK4007","SPRY","LU0650527681.SGD","BK4139","LU0594300179.USD","LU1861220033.SGD","BK4142","BK4585","LU0605514214.HKD","WBX","CRDO","ENVX","SMCI"],"gpt_icon":1},{"id":"2552349332","title":"ARS Pharmaceuticals announces UK MHRA approval of EURneffy","url":"https://stock-news.laohu8.com/highlight/detail?id=2552349332","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552349332?lang=en_us&edition=fundamental","pubTime":"2025-07-18 21:30","pubTimestamp":1752845412,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals (SPRY) announced that the United Kingdom Medicines and Healthcare products Regulatory Agency has granted approval for EURneffy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-announces-uk-mhra-approval-of-eurneffy-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-announces-uk-mhra-approval-of-eurneffy-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2552498493","title":"ARS Pharmaceuticals Inc. Secures UK Regulatory Approval for EURneffy, the First Needle-Free Adrenaline Treatment for Severe Allergies","url":"https://stock-news.laohu8.com/highlight/detail?id=2552498493","media":"Reuters","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552498493?lang=en_us&edition=fundamental","pubTime":"2025-07-18 21:25","pubTimestamp":1752845137,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc. Secures UK Regulatory Approval for EURneffy, the First Needle-Free Adrenaline Treatment for Severe Allergies. SAN DIEGO, July 18, 2025  -- ARS Pharmaceuticals, Inc. , a biopharmaceutical company focused on innovative treatments for allergic reactions, announced that the United Kingdom's Medicines and Healthcare products Regulatory Agency  has granted approval for EURneffy, an adrenaline nasal spray, for the emergency treatment of allergic reactions  in adults and children over 30 kg. This marks the first and only needle-free emergency treatment available in the U.K. for severe allergies, offering a new delivery method for adrenaline. The approval is a significant milestone in ARS Pharma's collaboration with ALK-Abelló A/S, who will market EURneffy in the U.K., with expected availability in late Q3 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely infor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDLqzv30:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","BK4585","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","SPRY","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","BK4139"],"gpt_icon":0},{"id":"2549547371","title":"Top Growth Companies With Strong Insider Ownership In July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2549547371","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549547371?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:05","pubTimestamp":1751972735,"startTime":"0","endTime":"0","summary":"In the last week, the U.S. market has been flat, yet it has shown a robust 13% increase over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this context of steady growth and optimistic forecasts, identifying companies with strong insider ownership can be crucial as it often indicates confidence from those who know the business best.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/7121000-choice2-main-header/1585186688507","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7121000-choice2-main-header/1585186688507"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-cacc/credit-acceptance/news/top-growth-companies-with-strong-insider-ownership-in-july-2-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","CRDO","ENVX","BK4559","LU0605514214.HKD","RH","LU0543330566.HKD","BK4543","LU1861220033.SGD","BK4170","LU0650527681.SGD","LU0229945570.USD","BK4023","BK4213","SMCI","LU0390135688.USD","LU2360107168.USD","MUX","PROP","DQ","ATAT","BK4166","LU0594300179.USD","LU2290526834.HKD","BK4526","LU0390135506.SGD","BK4141","BK4139","BK4539","LU0594300419.USD","LU0053671581.USD","LU0390135332.USD","LU1861215975.USD","WBX","BK4017","BK4147","BK4096","SPRY","LU0300738605.USD","BK4519","CACC","LU0300738514.USD","BK4178","FTCI","ALAB","BK4142","BK4585"],"gpt_icon":0},{"id":"2549320390","title":"Top Growth Stocks With High Insider Ownership July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2549320390","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549320390?lang=en_us&edition=fundamental","pubTime":"2025-07-05 01:05","pubTimestamp":1751648733,"startTime":"0","endTime":"0","summary":"The United States market has shown positive momentum recently, with a 2.1% increase over the last week and a 14% rise in the past year, as all sectors have gained ground. In light of these strong market conditions and an anticipated annual earnings growth of 15%, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and potential for sustained growth.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/3112400-choice1-main-header/1585186606618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112400-choice1-main-header/1585186606618"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nyse-dao/youdao/news/top-growth-stocks-with-high-insider-ownership-july-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","FTCI","LU0650527681.SGD","BK4196","LU0594300179.USD","BK4588","BK4142","ENVX","ASTH","BK4173","BK4170","BK4204","LU0605514214.HKD","ATAT","CRDO","LU0053671581.USD","BK4539","LU1861215975.USD","BK4096","SMCI","BK4510","LU2290526834.HKD","LU0594300419.USD","LU1861220033.SGD","BK4141","PERF","RYAN","BK4213","BK4543","BK4023","BK4506","LU2360107168.USD","PROP","ALAB","BK4585","SPRY","DAO"],"gpt_icon":1},{"id":"2548387691","title":"Eric Karas, Chief Commercial Officer, Reports Disposal of Common Shares of ARS Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548387691","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548387691?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:22","pubTimestamp":1751574121,"startTime":"0","endTime":"0","summary":"Eric Karas, the Chief Commercial Officer of ARS Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDLc8731Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2548113887","title":"James E. Flynn Reports Disposal of Common Shares of ARS Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548113887","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548113887?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:43","pubTimestamp":1751402621,"startTime":"0","endTime":"0","summary":"James E. Flynn, a 10% owner, reported a disposal of common shares of ARS Pharmaceuticals Inc. on June 27, 2025. The form was filed by more than one reporting person, including Deerfield Private Design Fund III, L.P., and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL7gfqfp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2546759649","title":"ARS Pharmaceuticals Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546759649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546759649?lang=en_us&edition=fundamental","pubTime":"2025-06-27 04:15","pubTimestamp":1750968953,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc. held its 2025 Annual Meeting of Stockholders on June 25, 2025. During the meeting, stockholders elected Richard Lowenthal, Peter Kolchinsky, Brenton L. Saunders, and Peter A. Thompson as Class II directors. Additionally, stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 26, 2025, and is solely responsible fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL8NFX6x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2545105314","title":"Eric Karas, Chief Commercial Officer, Reports Disposal of Common Shares in ARS Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2545105314","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545105314?lang=en_us&edition=fundamental","pubTime":"2025-06-21 06:39","pubTimestamp":1750459169,"startTime":"0","endTime":"0","summary":"Eric Karas, the Chief Commercial Officer of ARS Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL81vDPS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eric Karas, Chief Commercial Officer, Reports Disposal of Common Shares in ARS Pharmaceuticals Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2540121700","title":"William Blair Remains a Buy on ARS Pharmaceuticals (SPRY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540121700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540121700?lang=en_us&edition=fundamental","pubTime":"2025-06-04 06:15","pubTimestamp":1748988920,"startTime":"0","endTime":"0","summary":"William Blair analyst Lachlan Hanbury Brown reiterated a Buy rating on ARS Pharmaceuticals (SPRY – Research Report) today. The company’s shares clo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-remains-a-buy-on-ars-pharmaceuticals-spry-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-remains-a-buy-on-ars-pharmaceuticals-spry-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2537927282","title":"Brent L. Saunders, Director, Reports Disposal of Common Shares in ARS Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927282","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927282?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:01","pubTimestamp":1747947668,"startTime":"0","endTime":"0","summary":"Brent L. Saunders, a Director at ARS Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL37VsQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2537927453","title":"Alexander A. Fitzpatrick, Chief Legal Officer, Reports Disposal of Common Shares of ARS Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927453","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927453?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:00","pubTimestamp":1747947653,"startTime":"0","endTime":"0","summary":"Alexander A. Fitzpatrick, the Chief Legal Officer of ARS Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL2MMchV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2535882288","title":"Raymond James Keeps Their Buy Rating on ARS Pharmaceuticals (SPRY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535882288","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535882288?lang=en_us&edition=fundamental","pubTime":"2025-05-15 22:36","pubTimestamp":1747319786,"startTime":"0","endTime":"0","summary":"In a report released today, Ryan Deschner from Raymond James maintained a Buy rating on ARS Pharmaceuticals (SPRY – Research Report), with a price ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/raymond-james-keeps-their-buy-rating-on-ars-pharmaceuticals-spry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/raymond-james-keeps-their-buy-rating-on-ars-pharmaceuticals-spry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RJF","SPRY"],"gpt_icon":0},{"id":"1155819446","title":"Stock Track | ARS Pharmaceuticals Soars 11.57% Following Strong Q1 Results and Positive Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1155819446","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155819446?lang=en_us&edition=fundamental","pubTime":"2025-05-15 09:50","pubTimestamp":1747273854,"startTime":"0","endTime":"0","summary":"Shares of ARS Pharmaceuticals Inc  experienced a significant surge, soaring 11.57% on Wednesday, following the release of the company's impressive first-quarter 2025 financial results. The biotechnology and medical research firm's performance exceeded analyst expectations in key areas, sparking investor enthusiasm.Investors were particularly encouraged by ARS Pharmaceuticals' solid cash position, with the company reporting cash and investments of $275.7 million at the end of the quarter. This st","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SPRY"],"gpt_icon":0},{"id":"1130142281","title":"Stock Track | ARS Pharmaceuticals (SPRY) Soars 11.57% as Q1 Results Beat Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1130142281","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130142281?lang=en_us&edition=fundamental","pubTime":"2025-05-15 09:50","pubTimestamp":1747273849,"startTime":"0","endTime":"0","summary":"Shares of ARS Pharmaceuticals Inc  surged 11.57% in a 24-hour period, following the release of the company's first-quarter 2025 financial results that exceeded analyst expectations. The biotechnology and medical research firm's strong performance and positive outlook have fueled investor enthusiasm.ARS Pharmaceuticals reported Q1 revenue of $7.97 million, surpassing the mean analyst estimate of $7.48 million. While the company posted a quarterly adjusted loss of 35 cents per share, it met the co","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SPRY"],"gpt_icon":0},{"id":"1178365579","title":"Stock Track | ARS Pharmaceuticals Soars 5.79% After-Hours on Strong Q1 Revenue Beat and In-Line EPS","url":"https://stock-news.laohu8.com/highlight/detail?id=1178365579","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178365579?lang=en_us&edition=fundamental","pubTime":"2025-05-15 07:10","pubTimestamp":1747264247,"startTime":"0","endTime":"0","summary":"Shares of ARS Pharmaceuticals Inc  surged 5.79% in after-hours trading on Wednesday, following the release of the company's first-quarter 2025 financial results that exceeded analyst expectations in key areas.The biotechnology and medical research firm reported Q1 revenue of $7.97 million, surpassing the mean analyst estimate of $7.48 million. While the company posted a quarterly adjusted loss of 35 cents per share, it met the consensus expectation of six analysts. The reported net loss for the ","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SPRY"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"SPRY","fiscalQuarterEnding":"2025/03","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-03-20","symbol":"SPRY","fiscalQuarterEnding":"2024/12","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":0.52},{"market":"US","date":"2025-01-13","symbol":"SPRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"SPRY","fiscalQuarterEnding":"2024/09","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-08-06","symbol":"SPRY","fiscalQuarterEnding":"2024/06","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1741492800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2025-07-25","current":-112.459234,"percent":0.007634,"low":-115.157754,"twenty":-30.612951,"median":-18.156476,"eighty":-11.967761,"high":184.020638,"avg":-15.399478,"sd":50.657386,"marketCap":1759987013},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.313866,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":860429873},{"date":"2024-06-07","current":-17.177383,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":853647205},{"date":"2024-06-14","current":-16.884919,"twenty":-27.543213,"median":-15.872834,"eighty":-9.957071,"marketCap":839112916},{"date":"2024-06-21","current":-15.929536,"twenty":-27.026227,"median":-15.872834,"eighty":-9.981995,"marketCap":791634241},{"date":"2024-06-28","current":-16.592455,"twenty":-26.233342,"median":-15.857321,"eighty":-10.038073,"marketCap":824578628},{"date":"2024-07-05","current":-17.742813,"twenty":-26.122559,"median":-15.901185,"eighty":-10.097267,"marketCap":881746829},{"date":"2024-07-12","current":-22.129772,"twenty":-26.004391,"median":-15.977907,"eighty":-10.112844,"marketCap":1099761155},{"date":"2024-07-19","current":-20.550467,"twenty":-25.84191,"median":-16.008119,"eighty":-10.131537,"marketCap":1021275998},{"date":"2024-07-26","current":-21.408361,"twenty":-25.598187,"median":-16.06602,"eighty":-10.234348,"marketCap":1063909910},{"date":"2024-08-02","current":-19.302621,"twenty":-25.251068,"median":-16.155521,"eighty":-10.620668,"marketCap":959263034},{"date":"2024-08-09","current":-23.520911,"twenty":-24.881793,"median":-16.206368,"eighty":-10.941562,"marketCap":1054724705},{"date":"2024-08-16","current":-28.81744,"twenty":-25.84191,"median":-16.286222,"eighty":-11.035026,"marketCap":1292231647},{"date":"2024-08-23","current":-28.017556,"twenty":-27.270827,"median":-16.393243,"eighty":-11.081758,"marketCap":1256363252},{"date":"2024-08-30","current":-28.060793,"twenty":-27.941591,"median":-16.401625,"eighty":-11.197031,"marketCap":1258302084},{"date":"2024-09-06","current":-24.558599,"twenty":-27.79336,"median":-16.442915,"eighty":-11.309188,"marketCap":1101256678},{"date":"2024-09-13","current":-28.752585,"twenty":-27.79336,"median":-16.472628,"eighty":-11.620736,"marketCap":1289323399},{"date":"2024-09-20","current":-31.930502,"twenty":-27.995938,"median":-16.576918,"eighty":-11.620736,"marketCap":1431827564},{"date":"2024-09-27","current":-30.95767,"twenty":-28.060793,"median":-16.631178,"eighty":-11.714201,"marketCap":1388203840},{"date":"2024-10-04","current":-30.67663,"twenty":-28.212122,"median":-16.751589,"eighty":-11.833393,"marketCap":1375601431},{"date":"2024-10-11","current":-31.39004,"twenty":-28.39555,"median":-16.860498,"eighty":-11.83882,"marketCap":1407592162},{"date":"2024-10-18","current":-34.567957,"twenty":-28.752585,"median":-16.884919,"eighty":-11.967761,"marketCap":1550096327},{"date":"2024-10-25","current":-31.930502,"twenty":-28.968769,"median":-17.021402,"eighty":-12.05734,"marketCap":1431827564},{"date":"2024-11-01","current":-32.989808,"twenty":-29.172776,"median":-17.10772,"eighty":-12.236498,"marketCap":1479328953},{"date":"2024-11-08","current":-36.837898,"twenty":-29.53085,"median":-17.177383,"eighty":-12.27233,"marketCap":1651885017},{"date":"2024-11-15","current":-27.728261,"twenty":-29.574087,"median":-17.203935,"eighty":-12.290246,"marketCap":1361568504},{"date":"2024-11-22","current":-27.708469,"twenty":-29.53085,"median":-17.216378,"eighty":-12.329028,"marketCap":1360596650},{"date":"2024-11-29","current":-28.717849,"twenty":-29.510269,"median":-17.294264,"eighty":-12.329028,"marketCap":1410161242},{"date":"2024-12-06","current":-27.748052,"twenty":-29.318167,"median":-17.323614,"eighty":-12.355333,"marketCap":1362540359},{"date":"2024-12-13","current":-23.552198,"twenty":-29.200708,"median":-17.377363,"eighty":-12.390575,"marketCap":1156507152},{"date":"2024-12-20","current":-22.127191,"twenty":-29.174826,"median":-17.429503,"eighty":-12.426406,"marketCap":1086533610},{"date":"2024-12-27","current":-21.355313,"twenty":-29.123341,"median":-17.460097,"eighty":-12.465821,"marketCap":1048631275},{"date":"2025-01-03","current":-22.146983,"twenty":-29.064257,"median":-17.508842,"eighty":-12.501652,"marketCap":1087505465},{"date":"2025-01-10","current":-22.245942,"twenty":-29.025066,"median":-17.556082,"eighty":-12.530317,"marketCap":1092364739},{"date":"2025-01-17","current":-24.878247,"twenty":-29.013807,"median":-17.625827,"eighty":-12.566149,"marketCap":1221621420},{"date":"2025-01-24","current":-27.866803,"twenty":-28.968769,"median":-17.665522,"eighty":-12.594815,"marketCap":1368371488},{"date":"2025-01-31","current":-25.768876,"twenty":-28.968769,"median":-17.692748,"eighty":-12.61273,"marketCap":1265354884},{"date":"2025-02-07","current":-23.591782,"twenty":-28.81744,"median":-17.719962,"eighty":-12.684394,"marketCap":1158450862},{"date":"2025-02-14","current":-23.7897,"twenty":-28.81245,"median":-17.725862,"eighty":-12.70231,"marketCap":1168169409},{"date":"2025-02-21","current":-22.245942,"twenty":-28.80529,"median":-17.742813,"eighty":-12.730975,"marketCap":1092364739},{"date":"2025-02-28","current":-20.741768,"twenty":-28.766646,"median":-17.750677,"eighty":-12.878556,"marketCap":1018503778},{"date":"2025-03-07","current":-21.474063,"twenty":-28.753554,"median":-17.783612,"eighty":-12.988431,"marketCap":1054462403},{"date":"2025-03-14","current":-23.492823,"twenty":-28.724796,"median":-17.918291,"eighty":-13.032048,"marketCap":1153591588},{"date":"2025-03-21","current":151.633005,"twenty":-28.645299,"median":-17.929848,"eighty":-12.988431,"marketCap":1212760777},{"date":"2025-03-28","current":153.227851,"twenty":-28.604711,"median":-17.78435,"eighty":-12.670061,"marketCap":1225516351},{"date":"2025-04-04","current":157.030944,"twenty":-28.551598,"median":-17.756493,"eighty":-12.515985,"marketCap":1255933491},{"date":"2025-04-11","current":172.365997,"twenty":-28.537065,"median":-17.742813,"eighty":-12.355333,"marketCap":1378583246},{"date":"2025-04-17","current":182.548472,"twenty":-28.53527,"median":-17.728408,"eighty":-12.28308,"marketCap":1460022683},{"date":"2025-04-25","current":168.930945,"twenty":-28.478265,"median":-17.719962,"eighty":-11.916185,"marketCap":1351109701},{"date":"2025-05-02","current":177.55989,"twenty":-28.413636,"median":-17.701176,"eighty":-11.620736,"marketCap":1420124003},{"date":"2025-05-09","current":165.034919,"twenty":-28.363303,"median":-17.672598,"eighty":-11.047488,"marketCap":1319949281},{"date":"2025-05-16","current":-85.348526,"twenty":-28.478265,"median":-17.679674,"eighty":-10.985179,"marketCap":1335704429},{"date":"2025-05-23","current":-91.122103,"twenty":-28.610323,"median":-17.701176,"eighty":-11.047488,"marketCap":1426060905},{"date":"2025-05-30","current":-97.209461,"twenty":-28.755493,"median":-17.719962,"eighty":-11.103567,"marketCap":1521328059},{"date":"2025-06-06","current":-84.344425,"twenty":-28.908237,"median":-17.728408,"eighty":-11.22507,"marketCap":1319990259},{"date":"2025-06-13","current":-90.369027,"twenty":-29.139819,"median":-17.742813,"eighty":-11.433807,"marketCap":1414275278},{"date":"2025-06-20","current":-99.845224,"twenty":-29.414401,"median":-17.756493,"eighty":-11.620736,"marketCap":1562577755},{"date":"2025-06-27","current":-113.463334,"twenty":-29.625971,"median":-17.78435,"eighty":-11.639429,"marketCap":1775701182},{"date":"2025-07-03","current":-103.673356,"twenty":-29.970507,"median":-17.918291,"eighty":-11.714201,"marketCap":1622488027},{"date":"2025-07-11","current":-112.835772,"twenty":-30.109473,"median":-17.96922,"eighty":-11.833393,"marketCap":1765879826},{"date":"2025-07-18","current":-115.157754,"twenty":-30.373971,"median":-18.060207,"eighty":-11.83882,"marketCap":1802218844},{"date":"2025-07-25","current":-112.459234,"twenty":-30.612951,"median":-18.156476,"eighty":-11.967761,"marketCap":1759987013}],"updateTime":1753765251808}}}